
Oligonucleotide Production Scientist
Oxford Nanopore Technologies | Harwell Campus
We are seeking an Oligonucleotide Production Scientist to join our Oligonucleotide Facility Production team. This is an exciting opportunity to work within a collaborative, multidisciplinary environment supporting the manufacture and optimisation of oligonucleotides used in Oxford Nanopore's sequencing technology.
As part of a team focused on innovation, quality and continuous improvement, you will play a key role in the production, characterisation and delivery of high-quality oligonucleotides while helping to ensure the smooth day-to-day operation of the laboratory.
The Role
Based at our Harwell Campus site, you will support oligonucleotide production activities, maintain laboratory operations and contribute to process development within an ISO 9001-compliant environment. This role is ideal for someone with strong laboratory experience, excellent attention to detail and a proactive approach to problem-solving.
Key Responsibilities
About You
We're looking for a motivated scientist with laboratory experience in a relevant scientific discipline who enjoys working in a collaborative, fast-paced environment.
You will ideally have:
Desirable Experience
Join us and help develop the technologies that are enabling researchers to sequence anything, anywhere.
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability, or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
#LI-LH1
#LI-onsite
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.

Our goal is to enable the analysis of anything, anywhere, by anyone.
We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.
Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide.
Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.